Top compounds associated with response to KMT5C


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-14
mRNA PX-12 CTRPv2 pan-cancer AAC 0.21 7e-13
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 6e-11
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.22 6e-11
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.24 7e-11
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 8e-10
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-09
Download CSV